Publication:
Nebulised heparin for patients on ventilation: implications for COVID-19 pneumonia

Simple item page
dc.contributor.authorLorenzo Ballen_US
dc.contributor.authorMarcus J. Schultzen_US
dc.contributor.authorPaolo Pelosien_US
dc.contributor.otherIRCCS San Martino Polyclinic Hospitalen_US
dc.contributor.otherUniversità degli Studi di Genovaen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherNuffield Department of Medicineen_US
dc.contributor.otherAmsterdam UMC - University of Amsterdamen_US
dc.date.accessioned2022-08-04T09:27:52Z
dc.date.available2022-08-04T09:27:52Z
dc.date.issued2021-04-01en_US
dc.identifier.citationThe Lancet Respiratory Medicine. Vol.9, No.4 (2021), 321-322en_US
dc.identifier.doi10.1016/S2213-2600(20)30513-0en_US
dc.identifier.issn22132619en_US
dc.identifier.issn22132600en_US
dc.identifier.other2-s2.0-85100690597en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/78323
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85100690597&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleNebulised heparin for patients on ventilation: implications for COVID-19 pneumoniaen_US
dc.typeNoteen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85100690597&origin=inwarden_US

Files

Collections

Scopus 2021